NORDIC VACCINE TECHNOLOGY AS has a total of 15 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), New Zealand and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are ONYVAX LTD, HENDERSON MORLEY PLC and O'HAGAN DEREK.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | New Zealand | 3 | |
#3 | Canada | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | China | 1 | |
#7 | Japan | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Dalsgaard Kristian | 10 |
#2 | Kirkby Nikolai Soeren | 6 |
#3 | Kirkby Nikolai Soren | 6 |
#4 | Samuelsen Peter Boman | 3 |
#5 | Kirkby Nikolai S Ren | 1 |
#6 | Samuelsen Peter B | 1 |
#7 | Boman Kirkby Nikolai Soeren Sa | 1 |
#8 | Kirkby Nikolai S | 1 |
Publication | Filing date | Title |
---|---|---|
AU2007202515A1 | Polynucleotide binding complexes comprising sterols and saponins | |
EP1409009A1 | Therapeutical vaccination | |
US7713942B2 | Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides | |
EP1377320A2 | Polynucleotide binding complexes comprising sterols and saponins |